Cargando…
Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report
RATIONAL: Hemocoagulase, a hemostatic, is used in patients with trauma, gastrointestinal bleeding, or pulmonary hemorrhage or those undergoing surgery. However, paradoxical bleeding after hemocoagulase administration is not considered a clinically significant adverse effect. Here, we report a case o...
Autores principales: | Kim, Tae-Ok, Kim, Min-Suk, Kho, Bo Gun, Park, Ha Young, Kwon, Yong-Soo, Kim, Yu-Il, Lim, Sung-Chul, Shin, Hong-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850761/ https://www.ncbi.nlm.nih.gov/pubmed/33530198 http://dx.doi.org/10.1097/MD.0000000000024040 |
Ejemplares similares
-
Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
por: Lee, Jae-Kyeong, et al.
Publicado: (2022) -
Efficacy of an inpatient smoking cessation program at a single regional cancer center: A prospective observational study
por: Park, Ha-Young, et al.
Publicado: (2021) -
A Case Report of Cannabis Induced Hemoptysis
por: Hashmi, Hafiz Rizwan Talib, et al.
Publicado: (2016) -
Dieulafoy disease of the trachea with recurrent episodes of massive hemoptysis: A case report
por: Yang, Danrong, et al.
Publicado: (2017) -
Case report of a young male, with recurrent pneumothorax, hemoptysis and intrapulmonary cavitary lesions
por: Junping, Sun, et al.
Publicado: (2023)